Home News Archives - UNC Lineberger Comprehensive Cancer Center

Headshots of Adam Goldstein and Marc Bjurlin.

Adam Goldstein, MD, MPH, and Marc Bjurlin, DO, MSc, call for shared decision-making about prostate cancer screening to be built into health care systems, not left to individual clinicians alone, in a new editorial in the Journal of Urology.

Headshots of Jen Jen Yeh and Joseph DeSimone

A precision drug delivery technology with roots at UNC-Chapel Hill has launched a first-in-human phase I clinical trial of its iontophoretic oncology platform (IOP) for pancreatic cancer, now open for enrollment.

Saif Khairat, PhD, MPH, FAMIA, School of Nursing professor and UNC Lineberger member, will shepherd Carolina’s vision of ensuring that the invention, use and governance of AI serves the public good.

A patient having a spot checked on their back by a dermatologist.

A new form of immunotherapy called tumor-infiltrating lymphocyte (TIL) therapy is offering hope to some patients with metastatic melanoma who have few remaining treatment options.

UNC Lineberger members will share their latest research findings and clinical insights during the American Society of Clinical Oncology’s annual meeting in Chicago, taking place May 30 – June 3.

Illustration of gastrointestinal tract with a magnifying glass.

A new analysis of clinical trial data led by Anisha P. Ganguly, MD, MPH, has proven that mailed fecal immunochemical tests can drastically increase colorectal cancer screening by 18% across multiple racial/ethnic groups.

Marc Bjurlin, DO, MSc, vice chair of research and director of clinical trials in the department of urology, joined experts from around the world in Milan, Italy, for the 10th European Conference on Tobacco or Health.

UNC Lineberger's Justin Milner, PhD, has emerged in recent years as a young scientist to watch in the field of cancer immunology.

The ACS has honored Noel Brewer, PhD, with its Volunteer Leadership Award, which recognizes those who have taken on major volunteer leadership roles for ACS or have given many years of exceptional service across the organization.

Jeremy R. Wang, PhD, and colleagues have created a new way for oncologists to more sensitively detect genetic mutations in B-cell acute lymphoblastic leukemia (B-ALL), the most common type of pediatric cancer.

Tag: Home News

UNC physician experts call for systems-based approach to prostate cancer screening decisions

Drug delivery technology developed by UNC researchers enters first-in-human clinical trial for pancreatic cancer

Saif Khairat to serve as chief AI officer

What is TIL therapy?

UNC Lineberger members to present at American Society of Clinical Oncology Annual Meeting

UNC study shows strong patient response to at-home colorectal cancer screening

Bjurlin advances global dialogue on tobacco and bladder cancer at European conference

Engineering better cancer fighters: In conversation with Justin Milner

Brewer receives American Cancer Society’s Volunteer Leadership Award

UNC researchers develop faster, low-cost method to diagnose common pediatric cancer